Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field September 12, 2023September 13, 2023 CRI Staff
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies August 16, 2023August 16, 2023 CRI Staff